Banco Santander, S.A. (0HLE)
London Exchange · UK · prices in USD · close of 23 Oct 2026
Key indicators
| Last close | USD 12.77 |
|---|---|
| 52-week range | 9.67 – 15.07 |
| Return, 1 month / 3 months | −10.4% / −3.1% |
| Return, 1 year / 3 years | +34.6% / +294.7% |
| Trend | Below its 200-day average |
| RSI (14) | 33 |
| Volatility (1 year) | 30.1% |
| Worst drawdown (1 year) | -19.3% |
| Average daily value traded | 1.34M USD |
| Dividend yield | 2.5% |
Market X-Ray price-based
Five-year price chart navy: price · brown: 200-day average
About the company
Banco Santander is a banking group based in Spain that provides retail and commercial banking services to individuals, small businesses and larger companies. It serves customers through local banks and branches in European countries and across the Americas, offering current accounts, savings, mortgages, loans, cards and payment services, along with insurance and asset management products. Its consumer finance arm works with retailers and partners to provide point-of-sale lending.
Banco Santander, S.A. trades under the code 0HLE on the London Exchange in UK, with its price quoted in US dollars (USD). Our dividend records, which start in 2019, show payments in 6 different calendar years. The Market X-Ray on this page is price-based and compares it with other stocks on the same exchange; it does not measure how healthy the business is.
Summary
Banco Santander, S.A. (0HLE) trades on the London Exchange in UK. It last closed at USD 12.77 on 23 October 2026.
Its price-based Market X-Ray is 64 out of 100 (a fair price profile), ranking 1,016 of 3,787 stocks on this exchange. The score describes how the stock has traded: trend, momentum, risk, liquidity and dividends, each ranked against the other stocks on its own exchange. It does not measure how healthy or cheap the business is.
Over the last year the price rose 34.6% and over the last three months it fell 3.1%. Returns are price returns, dividends not included.
Fundamental measures (valuation, growth, financial health) are not shown: we do not yet hold financial statements for this market.
The five lenses in numbers each metric is ranked against the other stocks on London Exchange
| Lens and metric | Value | Score | Reading |
|---|---|---|---|
| Trend | 61 · Fair | Mixed trend against its averages. | |
| Above 200-day average | -1.2% | ||
| From 52-week high | -14.4% | ||
| Momentum | 66 · Fair | Typical recent returns for this exchange. | |
| 3-month return | -3.1% | ||
| 6-month return | 8.5% | ||
| 12-month return, skipping the last month | 50.2% | ||
| Stability (higher is calmer) | 68 · Fair | Typical risk for this exchange. | |
| Volatility, 1 year (lower is calmer) | 30.1% | ||
| Worst drawdown, 1 year (smaller is calmer) | -19.3% | ||
| Liquidity | 56 · Fair | Moderate trading activity. | |
| Average daily value traded | 1.34M USD | ||
| Zero-volume days | 1.7% | ||
| Income | 63 · Fair | Dividend is typical for this exchange. | |
| Dividend yield | 2.5% | ||
| Years with dividends | 6 |
Strengths
No lens stands out as a clear strength against its exchange.
Weak spots
No lens is weak against its exchange.
Returns
| 1 week | −3.7% |
|---|---|
| 1 month | −10.4% |
| 3 months | −3.1% |
| 6 months | +8.5% |
| 1 year | +34.6% |
| 3 years | +294.7% |
| 5 years | +295.2% |
Signals
| 50-day / 200-day average | 14.14 / 12.92 |
|---|---|
| Golden / death cross (60 days) | None |
| New 52-week high | No |
| Bullish RSI divergence | No |
| Average daily range (ATR) | 0.33 |
Technical summary
Recent dividends
| Ex-dividend date | Amount per share |
|---|---|
| 5 May 2026 | EUR 0.1460 |
| 31 Oct 2025 | EUR 0.1323 |
| 30 Apr 2025 | EUR 0.1241 |
| 31 Oct 2024 | EUR 0.1085 |
| 29 Apr 2024 | EUR 0.1015 |
| 31 Oct 2023 | EUR 0.0858 |
How to read this report
Every number comes from end-of-day prices and dividends. The Market X-Ray describes how the stock has traded, ranked against the other stocks on London Exchange; it does not measure how healthy or cheap the business is. The fundamental X-Ray (financial health, valuation, growth) needs financial statements, which we hold today for US stocks. See the methodology page. Educational only, not financial advice.